These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30666909)

  • 21. MT-MMPs play pivotal roles in cancer dissemination.
    Yana I; Seiki M
    Clin Exp Metastasis; 2002; 19(3):209-15. PubMed ID: 12067201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Tissue Inhibitors of Metalloproteinases in Organ Development and Regulation of ADAMTS Family Metalloproteinases in
    Kubota Y; Nishiwaki K; Ito M; Sugimoto A
    Genetics; 2019 Jun; 212(2):523-535. PubMed ID: 30992386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in Extracellular Matrix/Bruch's Membrane Can Cause the Activation of the Alternative Complement Pathway via Tick-Over.
    Fernandez-Godino R
    Adv Exp Med Biol; 2018; 1074():29-35. PubMed ID: 29721924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related changes of cystatin C expression and polarized secretion by retinal pigment epithelium: potential age-related macular degeneration links.
    Kay P; Yang YC; Hiscott P; Gray D; Maminishkis A; Paraoan L
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):926-34. PubMed ID: 24458156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics.
    Sparrow JR
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4564-9. PubMed ID: 27071115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).
    Nashine S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration.
    Erie JC; Good JA; Butz JA; Pulido JS
    Am J Ophthalmol; 2009 Feb; 147(2):276-282.e1. PubMed ID: 18848316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway.
    Fernandez-Godino R; Bujakowska KM; Pierce EA
    Hum Mol Genet; 2018 Jan; 27(1):147-159. PubMed ID: 29095988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases in inflammatory pathologies of the horse.
    Clutterbuck AL; Harris P; Allaway D; Mobasheri A
    Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
    Pohl M; Sakurai H; Bush KT; Nigam SK
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration.
    Bennis A; Gorgels TG; Ten Brink JB; van der Spek PJ; Bossers K; Heine VM; Bergen AA
    PLoS One; 2015; 10(10):e0141597. PubMed ID: 26517551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-25 Mediates Retinal Degeneration Via Inhibiting ITGAV and PEDF in Rat.
    Zhang J; Wang J; Zheng L; Wang M; Lu Y; Li Z; Lian C; Mao S; Hou X; Li S; Xu J; Tian H; Jin C; Gao F; Zhang J; Wang F; Li W; Lu L; Xu GT
    Curr Mol Med; 2017; 17(5):359-374. PubMed ID: 29210651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway.
    Fernandez-Godino R; Pierce EA
    Sci Rep; 2018 Jun; 8(1):9679. PubMed ID: 29946065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y; Goldberg ID; Shi YE
    Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.